Family Capital Trust’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.17M Hold
8,636
0.71% 39
2026
Q1
$1.88M Buy
8,636
+41
+0.5% +$9.1K 0.68% 37
2025
Q4
$1.96M Buy
8,595
+102
+1% +$23.2K 0.64% 37
2025
Q3
$1.97M Buy
+8,493
New +$1.73M 0.66% 33
2015
Q3
Sell
-270
Closed -$18K 85
2015
Q2
$18K Buy
+270
New +$17.6K 0.01% 70
2015
Q1
Sell
-382
Closed -$25K 80
2014
Q4
$25K Buy
+382
New +$24.1K 0.01% 80

Other funds holding ABBV

Family Capital Trust's ABBV Position: Q2 2026 in Review

Family Capital Trust held its AbbVie (ABBV) position steady in Q2 2026 at 8,636 shares worth $2.17M. The position accounts for 0.71% of the portfolio, ranked #39.

Family Capital Trust first reported a position in ABBV in Q4 2014 and has held it in 6 quarters since. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Family Capital Trust held 8,636 shares of AbbVie worth $2.17M as of Q2 2026.
  • Family Capital Trust left its AbbVie share count unchanged in Q2 2026.
  • AbbVie made up 0.71% of Family Capital Trust's portfolio in Q2 2026, its #39 holding.
  • Family Capital Trust first reported a position in AbbVie in Q4 2014 and has held it in 6 quarters since.
  • 2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Family Capital Trust's 13F filing for Q2 2026, filed 29 Jul 2026.